HRT Financial’s Chembio diagnostics, Inc. CEMI Stock Holding History

HRT Financial’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-96,434	Closed	-$42K	–	3688
2023 Q1	$42K	Buy	+96,434	New	+$37.8K	﹤0.01%	2140
2022 Q4	–	Sell	-33,463	Closed	-$12K	–	3855
2022 Q3	$12K	Buy	+33,463	New	+$22.8K	﹤0.01%	2530
2022 Q1	–	Sell	-18,957	Closed	-$21K	–	4261
2021 Q4	$21K	Buy	+18,957	New	+$38.6K	﹤0.01%	2950
2021 Q3	–	Sell	-56,473	Closed	-$167K	–	4115
2021 Q2	$167K	Buy	+56,473	New	+$197K	﹤0.01%	2456

Other funds holding CEMI

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HRT Financial's CEMI Position: Q2 2023 in Review

HRT Financial sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 96,434 shares — an estimated $42K sold.

HRT Financial first reported a position in CEMI in Q2 2021 and held it in 4 quarters. The position peaked at $167K in Q2 2021. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

HRT Financial reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
HRT Financial sold 96,434 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $42K.
HRT Financial first reported a position in Chembio diagnostics, Inc. in Q2 2021 and held it in 4 quarters.
HRT Financial's Chembio diagnostics, Inc. position peaked at $167K in Q2 2021.
1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.